Diagnosis and Management of Unilateral Pustular Facial Rash

Primary Diagnostic Consideration

The American Academy of Dermatology suggests that herpes zoster should be the leading diagnosis when pustular lesions follow a unilateral, dermatomal distribution on the face, with a strict unilateral presentation respecting the midline, which is pathognomonic for reactivation of varicella-zoster virus along a sensory nerve distribution 1, 2
The key distinguishing feature of herpes zoster is the distribution pattern of pustules following a dermatomal pattern (typically V1, V2, or V3 trigeminal nerve distribution) that stops at the facial midline, with associated symptoms including prodromal pain, burning, or tingling in the affected dermatome often preceding the rash by 1-5 days 1

The Centers for Disease Control and Prevention recommends initiating oral acyclovir immediately upon clinical diagnosis of herpes zoster without waiting for laboratory confirmation, with treatment started within 72 hours of rash onset for maximum efficacy 1
Early antiviral therapy reduces acute pain, accelerates healing, and decreases the risk of postherpetic neuralgia, with the American College of Physicians suggesting that patients who appear systemically ill or febrile, or those with mucosal involvement, should receive intravenous acyclovir 1

The American Academy of Dermatology recommends gentle skin care using non-irritating cleansers and avoiding frequent washing with hot water, as well as moisturization with alcohol-free moisturizers containing 5-10% urea twice daily to maintain skin barrier function 1, 2
The National Institute for Health and Care Excellence suggests avoiding irritants such as over-the-counter anti-acne medications, harsh soaps, solvents, or disinfectants 4, 2

The European Society for Medical Oncology recommends considering drug-induced papulopustular eruption as an alternative diagnosis, particularly if the patient is receiving anticancer therapy (EGFR inhibitors, MEK inhibitors), with treatment approaches including continuing the causative medication and initiating oral tetracyclines (doxycycline 100 mg twice daily OR minocycline 100 mg daily) for at least 6 weeks 7, 4
The Infectious Diseases Society of America suggests obtaining bacterial culture before initiating antibiotics if bacterial superinfection is suspected, with signs including failure to respond to initial treatment, presence of painful skin lesions, yellow crusts or purulent discharge, and systemic signs of infection 7, 4, 1

The American Academy of Dermatology advises against delaying antiviral therapy while awaiting laboratory confirmation in suspected herpes zoster, as clinical diagnosis is sufficient 1
The National Institute for Health and Care Excellence recommends avoiding topical anti-acne medications on pustular rashes, as these are irritants that worsen inflammation 4, 2

The American College of Physicians suggests urgent dermatology referral for grade 3-4 severity rashes, systemic symptoms (fever, malaise, hypotension), suspected autoimmune skin disease, no response to first-line treatment after 2 weeks, and need for skin biopsy for definitive diagnosis 1, 2, 7
The American Academy of Ophthalmology recommends immediate ophthalmology referral for any ocular symptoms or periorbital involvement in suspected herpes zoster, as well as Hutchinson's sign (lesions on tip of nose indicating nasociliary nerve involvement) 1, 7